Core Scientific vs Bitfufu
Bitfufu is the larger business, with $478m of revenue in fiscal 2025 against $319m for Core Scientific (1.5 times as much). Bitfufu grew faster (3.1% against -37.5%). Bitfufu kept more of each dollar of sales as profit: a net margin of -6.5% against -90.5%.
| Latest fiscal year | Core ScientificCORZ, 2025 | BitfufuFUFU, 2025 |
|---|---|---|
| Revenue | $319m | $478m |
| Revenue growth | -37.5% | 3.1% |
| Net income | −$289m | −$31.3m |
| Operating margin | -77.0% | -5.0% |
| Net margin | -90.5% | -6.5% |
| Return on equity | — | -20.0% |
| Free cash flow | −$451m | — |
| Cash | $311m | $27.8m |
| Total debt | $1.08bn | $109m |
| Debt to equity | — | 73.1% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 325 | — |
| Market value | $4.50bn | $168m |
| Price vs our value range | — | — |
| Moat score | 16 (Weak) | — |
| Insider trades, 12 months | 5 buys, 49 sales | 0 buys, 0 sales |